Action-effect Anticipation in Patients With Parkinson's Disease : A Study of the Sensory Attenuation Marker.
IDEOMOT
The Process of Sensory Anticipation in Patients With PARKINSON's Disease
1 other identifier
observational
1
1 country
2
Brief Summary
The ideomotor theory of action control is considered to be central to the understanding of human voluntary action. According to the ideomotor theory, an action is represented in terms of its desired sensory effects and actions are selected by internally activating these effect representations. Recent imagery and behavioral studies showed that this anticipated representation of action-effects triggered a "sensory attenuation", meaning a decrease of perceptive performances or a decrease of sensory event-related potentials (ERP) for an expected event. Thus, the sensory attenuation constitutes a relevant behavioral tool to investigate sensory anticipation impairment in patients with Parkinson's disease. In a behavioral paradigm, patients and matched control participants have to perform a perceptive task on predicted visual action-effects mixed with mispredicted visual action effects. Performances should be better in mispredicted visual action effects for control participants only.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for all trials
Started Dec 2015
Typical duration for all trials
2 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
December 1, 2015
CompletedFirst Submitted
Initial submission to the registry
September 5, 2016
CompletedFirst Posted
Study publicly available on registry
September 9, 2016
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 1, 2018
CompletedStudy Completion
Last participant's last visit for all outcomes
September 1, 2019
CompletedDecember 23, 2019
December 1, 2019
2.8 years
September 5, 2016
December 20, 2019
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
median score
scores measured with the Movement Disorder Society-sponsored revision of the Unified Parkinson's Disease Rating Scale (MDS-UPDRS)
baseline
Study Arms (1)
Patients with Parkinson's disease
Interventions
Eligibility Criteria
patients with Parkinson's disease
You may qualify if:
- Parkinson's disease
- Normal or corrected vision
You may not qualify if:
- Other pathology or neurological or psychiatric history
- Known pregnancy or breastfeeding
- Absence of affiliation to the French Social Security
- Person under legal protection
- Patient's opposition to participate
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (2)
Fondation Adolphe de Rothschild
Paris, 75019, France
Fondation Ophtalmologique Adolphe de Rothschild
Paris, 75019, France
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Design
- Study Type
- observational
- Observational Model
- OTHER
- Time Perspective
- CROSS SECTIONAL
- Sponsor Type
- NETWORK
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
September 5, 2016
First Posted
September 9, 2016
Study Start
December 1, 2015
Primary Completion
September 1, 2018
Study Completion
September 1, 2019
Last Updated
December 23, 2019
Record last verified: 2019-12